UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Novel venom-based peptides (P13 & its derivative -- M6) to maintain self-renewal of human embryonic stem cells by activating FGF and TGF-ß signaling pathways Journal article
Ma, R., Ren, Z., Li, B., Siu, W. I., Chen, G., Kwok, H. F.. Novel venom-based peptides (P13 & its derivative -- M6) to maintain self-renewal of human embryonic stem cells by activating FGF and TGF-ß signaling pathways[J]. Stem Cell Research & Therapy, 2020, 11(1), 243.
Authors:  Ma, R.;  Ren, Z.;  Li, B.;  Siu, W. I.;  Chen, G.; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:7.1/7.9 | Submit date:2022/06/02
Venom-based Peptide  Stem Cell Application  Fgfr And Tgfβ Receptors  
In vitro & in vivo characterization of novel scorpion venom-based peptides for the treatment of colon cancer Conference paper
Li, B., Kwok, H. F.. In vitro & in vivo characterization of novel scorpion venom-based peptides for the treatment of colon cancer[C], Philadelphia:The American Association for Cancer Research, 2017, 108-108.
Authors:  Li, B.;  Kwok, H. F.
Favorite |  | Submit date:2022/06/02
Venom-based Peptide  Colon Cancer  
Drugs with "Monster" Bite: Nature's Cruise Missiles Book chapter
出自: Umagazine, Macau:University of Macau, 2014, 页码:61-65
Authors:  Kwok, H. F.
Favorite |  | Submit date:2022/06/02
Drug discovery  Venom-based peptide  Cancer  Diabetes